Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2009, p. 3528-3533, Vol. 53, No. 8
0066-4804/09/$08.00+0 doi:10.1128/AAC.00178-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Tommaso Giani,1,
Silvia D'Arezzo,2,
Alessandro Capone,2
Nicola Petrosillo,2
Paolo Visca,2,3
Francesco Luzzaro,4,# and
Gian Maria Rossolini1,5*
Dipartimento di Biologia Molecolare, Sezione di Microbiologia, Università di Siena,1 Unità Operativa di Microbiologia e Virologia, Dipartimento dei Servizi, Azienda Ospedaliera-Universitaria Senese, I-53100 Siena,5 Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, I-00149 Roma,2 Dipartimento di Biologia, Università Roma Tre, I-00146 Roma,3 Laboratorio di Microbiologia Ospedale di Circolo, Università dell'Insubria, I-21100 Varese, Italy4
Received 9 February 2009/ Returned for modification 21 March 2009/ Accepted 21 May 2009
Two epidemiologically unrelated carbapenem-resistant Acinetobacter baumannii isolates were investigated as representatives of the first Italian isolates producing the OXA-24 carbapenemase. Both isolates were of European clonal lineage II and carried an identical OXA-24-encoding plasmid, named pABVA01. Comparative analysis revealed that in pABVA01, blaOXA-24 was part of a DNA module flanked by conserved inverted repeats homologous to XerC/XerD binding sites, which in other Acinetobacter plasmids flank different DNA modules, suggesting mobilization by a novel site-specific recombination mechanism.
Published ahead of print on 1 June 2009.
These authors contributed equally to this work.
# Present address: A. Manzoni Hospital, Lecco, Italy.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»